arginyl-glycyl-aspartic acid and Lymphoma, T-Cell

arginyl-glycyl-aspartic acid has been researched along with Lymphoma, T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Corti, A; Monaco, L; Zarovni, N	1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Lymphoma, T-Cell

Article	Year
Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor alpha coupled to NGR and RGD tumor-homing peptides. Human gene therapy, 2004, Volume: 15, Issue:4 Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; DNA, Complementary; Doxorubicin; Endothelium, Vascular; Feedback, Physiological; Female; Genetic Therapy; Injections, Intramuscular; Lymphoma, T-Cell; Melanoma, Experimental; Melphalan; Mice; Mice, Inbred C57BL; Oligopeptides; Peptide Fragments; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2004

Article

Year

Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor alpha coupled to NGR and RGD tumor-homing peptides.

Human gene therapy, 2004, Volume: 15, Issue:4

Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; DNA, Complementary; Doxorubicin; Endothelium, Vascular; Feedback, Physiological; Female; Genetic Therapy; Injections, Intramuscular; Lymphoma, T-Cell; Melanoma, Experimental; Melphalan; Mice; Mice, Inbred C57BL; Oligopeptides; Peptide Fragments; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2004